Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.

Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.

Item
http://www.wikidata.org/entity/Q33424981
Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal HemorrhagingTAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndromeAnasarca, Fever, Thrombocytopenia, Organomegaly, and Multiorgan Failure in a 24-Year-Old Pregnant Woman.Multicentric Castleman disease: Where are we now?Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
P2860

Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.

Item
http://www.wikidata.org/entity/Q33424981
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@ast
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@en
type
label
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@ast
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@en
prefLabel
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@ast
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Successful Treatment of TAFRO ...... Contribution of Interleukin-2.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921